Category: GenHenn Capital Venture

Auto Added by WPeMatico

PreciseDx Secures $20.7 Million Series B to Advance AI-Powered Cancer Risk Assessments

 admin  2024-09-13

PreciseDx Secures $20.7 Million Series B to Advance AI-Powered Cancer Risk Assessments Funding will Support Expanded Commercialization Efforts for PreciseBreast…